Researcher Roy Ben-Shalom is developing a model that simulates changes in neuronal activity caused by ion channel mutations to select the most effective therapy for many neurodevelopmental conditions.
Read MoreResearchers have infused their first Wilson Disease patient with a gene therapy which has the potential to treat the underlying cause of the disease.
Read MoreThe development of engineered bone marrow is revolutionizing research and treatment for osteosarcoma, the most common malignant bone cancer in children.
Read MoreThe specialist you see first for your neck pain has a big impact on how your condition gets diagnosed and treated, a UC Davis study has found
Read MoreUC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Read MoreA new UC Davis Health study examined women’s understanding of lactational amenorrhea, the period of temporary infertility that accompanies exclusive breastfeeding.
Read MoreUC Davis hematologist Brian Jonas awarded the National Cancer Institute Research Specialist Award (R50) to further his leadership in NCI-funded cancer research.
Read MoreDown syndrome can mean more X-rays — and more radiation exposure — for children already at increased risk of cancer.
Read MoreUC Davis and the University of Oxford researchers developed a new software tool, SparkMaster 2, that allows scientists to analyze normal and abnormal calcium activity in cells.
Read MoreMIND Institute Director Leonard Abbeduto has co-authored a paper in the American Journal on Intellectual and Developmental Disabilities that calls for a paradigm shift in disability research.
Read MoreAn experimental medicine being tested at the UC Davis Eye Center uses gene therapy as a possible treatment for wet age-related macular degeneration or wet AMD.
Read MoreUC Davis clinicians are developing a multiteam strategy to boost rates of long-term use of buprenorphine among patients who seek care for opioid use disorder in emergency departments.
Read MoreResearch at UC Davis to uncover the potential causes of cancer in firefighters is getting a boost from a California climate action grant.
Read MoreGene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.
Read MoreThe Congress of Neurological Surgeons has named a paper by UC Davis Health neurosurgeon Kee Kim as the "2023 Top Spine Paper of the Year.”
Read MoreResearchers at UC Davis Health and Kennedy Krieger Institute have received a grant to develop a clinical tool to predict mental health concerns in adolescents following a concussion.
Read MoreResearchers in the Department of Psychiatry and Behavioral Sciences and the MIND Institute have received $4.7 million from the National Institute of Mental Health to test a child-focused autism intervention with community partners.
Read MoreA 5-year-old boy diagnosed with Duchenne muscular dystrophy is the first in California and fourth in the nation to receive groundbreaking gene therapy outside of clinical trials.
Read MoreUC Davis Comprehensive Cancer Center scientist receives $1.4 million federal grant to boost efforts finding a breakthrough treatment for late stage, drug-resistant prostate cancer.
Read MoreCancer center launches joint research data bank with UC Davis School of Veterinary Medicine. Samples collected from pets with cancer may help unlock the mystery of cancer in people.
Read MoreA study led by the Goncharova Lab has validated a potential therapeutic option to treat pulmonary arterial hypertension, a condition that currently lacks effective treatments.
Read MoreThe 2023 Convocation marked largest ever gathering of fellows, national advisory council members, nurse leaders and program faculty.
Read MoreResults from a national clinical trial testing a new anti-cancer drug show that people with kidney cancer lived longer after taking the therapy following surgery.
Read MoreA new study involving mice suggests that patients with COVID‐19 may experience long‐term orthopedic issues, such as decreased bone mass, increased fracture risk, and other musculoskeletal complications.
Read MoreVolunteering in late life is associated with better cognitive function — specifically, better executive function and episodic memory, according to a new UC Davis study.
Read MoreHelping raise money for sarcoma research is now easier (and more fun) with the new UC Davis Comprehensive Cancer Center “hugabox collection.”
Read MoreThis fragile X awareness month, the NIH has renewed funding for a key study of the neurodegenerative condition fragile X-associated tremor ataxia syndrome (FXTAS).
Read MoreUC Davis Health received a CA Quits grant and a TRDRP research award that would help support initiatives and resources for people to stop smoking.
Read MoreA novel pancreatic cancer clinical trial at UC Davis Comprehensive Cancer Center is achieving critical acclaim within the nuclear medicine industry.
Read MoreUC Davis researchers join colleagues at Stanford and UCSF to study how helping people rise above persistent poverty may help prevent cancer.
Read More